MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,137,961 | -29.5% | 21,487 | +11.4% | 0.01% | -28.6% |
| Q2 2023 | $4,453,911 | +801.6% | 19,281 | +153.7% | 0.01% | +600.0% |
| Q3 2022 | $494,000 | -68.8% | 7,600 | -59.4% | 0.00% | -60.0% |
| Q4 2021 | $1,585,000 | +6.2% | 18,700 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,492,000 | -18.1% | 18,700 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,822,000 | +10.5% | 18,700 | +32.6% | 0.01% | -14.3% |
| Q1 2021 | $1,649,000 | -58.7% | 14,100 | -55.7% | 0.01% | -53.3% |
| Q1 2019 | $3,990,000 | -42.0% | 31,848 | -47.8% | 0.02% | -51.6% |
| Q4 2018 | $6,883,000 | -2.9% | 61,056 | +84.3% | 0.03% | +19.2% |
| Q3 2018 | $7,091,000 | +17.3% | 33,122 | +53.2% | 0.03% | +4.0% |
| Q2 2018 | $6,047,000 | – | 21,619 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |